Acceleration of the Healing Process and Myocardial Regeneration May Be Important as a Mechanism of Improvement of Cardiac Function and Remodeling by Postinfarction Granulocyte Colony–Stimulating Factor Treatment

Background—We investigated whether the improvement of cardiac function and remodeling after myocardial infarction (MI) by granulocyte colony–stimulating factor (G-CSF) relates to acceleration of the healing process, in addition to myocardial regeneration. Methods and Results—In a 30-minute coronary occlusion and reperfusion rabbit model, saline (S) or 10 μg · kg−1 · d−1 of human recombinant G-CSF (G) was injected subcutaneously from 1 to 5 days after MI. Smaller left ventricular (LV) dimension, increased LV ejection fraction, and thicker infarct-LV wall were seen in G at 3 months after MI. At 2, 7, and 14 days and 3 months after MI, necrotic tissue areas were 14.2±1.5/13.4±1.1, 0.4±0.1/1.8±0.5*, 0/0, and 0/0 mm2 ·· slice−1 · kg−1, granulation areas 0/0, 4.0±0.7/8.5±1.0*, 3.9±0.8/5.7±0.7,* and 0/0 mm2 · slice−1 kg−1, and scar areas 0/0, 0/0, 0/0, and 4.2±0.5/7.9±0.9* mm2 slice−1 kg−1 in G and S, respectively (*P <0.05, G versus S). Clear increases of macrophages and of matrix metalloproteinases (MMP) 1 and 9 were seen in G at 7 days after MI. This suggests that G accelerates absorption of necrotic tissues via increase of macrophages and reduces granulation and scar tissues via expression of MMPs. Meanwhile, surviving myocardial tissue areas within the risk areas were significantly increased in G despite there being no difference in LV weight, LV wall area, or cardiomyocyte size between G and S. Confocal microscopy revealed significant increases of cardiomyocytes with positive 3,3,3′3′-tetramethylindocarbocyanine perchlorate and positive troponin I in G, suggesting enhanced myocardial regeneration by G. Conclusions—The acceleration of the healing process and myocardial regeneration may play an important role for the beneficial effect of post-MI G-CSF treatment.

[1]  A. Luttun,et al.  Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure , 1999, Nature Medicine.

[2]  R. Visse,et al.  Matrix Metalloproteinases Regulation and Dysregulation in the Failing Heart , 2002 .

[3]  G. Takemura,et al.  Role of apoptosis in the disappearance of infiltrated and proliferated interstitial cells after myocardial infarction. , 1998, Circulation research.

[4]  Y. Taniyama,et al.  Potential contribution of a novel antifibrotic factor, hepatocyte growth factor, to prevention of myocardial fibrosis by angiotensin II blockade in cardiomyopathic hamsters. , 2000, Circulation.

[5]  E. Creemers,et al.  Matrix Metalloproteinase Inhibition After Myocardial Infarction: A New Approach to Prevent Heart Failure? , 2001, Circulation research.

[6]  David M. Bodine,et al.  Bone marrow cells regenerate infarcted myocardium , 2001, Nature.

[7]  I. Weissman,et al.  Little Evidence for Developmental Plasticity of Adult Hematopoietic Stem Cells , 2002, Science.

[8]  M. Arai,et al.  A novel anti‐diabetic drug, miglitol, markedly reduces myocardial infarct size in rabbits , 1999, British journal of pharmacology.

[9]  Federica Limana,et al.  Mobilized bone marrow cells repair the infarcted heart, improving function and survival , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[10]  J. Isner,et al.  Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. , 1999, Circulation research.

[11]  I. Vargel,et al.  Effects of Growth Factors on Doxorubicin-Induced Skin Necrosis: Documentation of Histomorphological Alterations and Early Treatment by GM-CSF and G-CSF , 2002, Annals of plastic surgery.

[12]  A. Salama,et al.  Matrix metalloproteinase‐9 (gelatinase B) is elevated during mobilization of peripheral blood progenitor cells by G–CSF , 2002, Transfusion.

[13]  Doris A Taylor,et al.  Cardiac chimerism as a mechanism for self-repair: does it happen and if so to what degree? , 2002, Circulation.

[14]  H. Saito,et al.  Granulocyte colony‐stimulating factor (G‐CSF)‐mediated signaling regulates type IV collagenase activity in head and neck cancer cells , 2001, International journal of cancer.

[15]  P. Libby,et al.  Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. , 2000, The Journal of clinical investigation.

[16]  Klaus Pfeffer,et al.  Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes , 2003, Nature.

[17]  D. Schuschke,et al.  The effect of severe burn injury on proinflammatory cytokines and leukocyte behavior: its modulation with granulocyte colony-stimulating factor. , 1999, Burns : journal of the International Society for Burn Injuries.

[18]  J. Isner,et al.  Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[19]  W. Krüger,et al.  A randomized comparison of once versus twice daily recombinant human granulocyte colony‐stimulating factor (filgrastim) for stem cell mobilization in healthy donors for allogeneic transplantation , 2000, British journal of haematology.